- Acalabrutinib 100mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Acalabrutinib 100mg tablets | Start Date 09-08-2023 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01EL02
- BNF Codes
-
- BNF code 08010500
Code | Start Date | End Date |
---|---|---|
42167511000001102 | 09-08-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Acalabrutinib maleate | Based on Base Substance | Acalabrutinib | 100 mg |
Name
Acalabrutinib maleate
Basis of strength description
Based on Base Substance
BOSS
Acalabrutinib
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
Parent Products
-
VTMAcalabrutinib
-
VMP(Current) Acalabrutinib 100mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
60 tablet |